Cargando…
Radiotherapy-activated NBTXR3 nanoparticles modulate cancer cell immunogenicity and TCR repertoire
BACKGROUND: Radiotherapy is a powerful and widely used technique for the treatment of solid tumors. Beyond its ability to destroy tumor cells, it has been demonstrated that radiotherapy can stimulate the anti-tumor immune response. Unfortunately, this effect is mainly restricted to the irradiated le...
Autores principales: | Darmon, Audrey, Zhang, Ping, Marill, Julie, Mohamed Anesary, Naeemunnisa, Da silva, Jordan, Paris, Sébastien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164428/ https://www.ncbi.nlm.nih.gov/pubmed/35659676 http://dx.doi.org/10.1186/s12935-022-02615-w |
Ejemplares similares
-
NBTXR3 Radiotherapy-Activated Functionalized Hafnium Oxide Nanoparticles Show Efficient Antitumor Effects Across a Large Panel of Human Cancer Models
por: Zhang, Ping, et al.
Publicado: (2021) -
Radiotherapy-Activated Hafnium Oxide Nanoparticles Produce Abscopal Effect in a Mouse Colorectal Cancer Model
por: Zhang, Ping, et al.
Publicado: (2020) -
Hafnium oxide nanoparticles: toward an in vitro predictive biological effect?
por: Marill, Julie, et al.
Publicado: (2014) -
NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model
por: Hu, Yun, et al.
Publicado: (2022) -
NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience
por: Bagley, Alexander F., et al.
Publicado: (2022)